News for Johnson & Johnson (DJNJ3.BA)

After hosting three meets this season, new track league Grand Slam Track makes decision to cancel its final meet in LA.

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why that isn’t a good idea.

Johnson & Johnson (NYSE:JNJ) Goldman Sachs 46th Annual Global Healthcare Conference Call June 11, 2025 3:20 PM ETCompany ParticipantsTom Cavanaugh -...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JNJ, TMUS, BA, and FRAF show strong momentum as earnings growth, market share, and strategic moves fuel investor confidence.

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, T-Mobile US, and The Boeing Company.

Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to dismiss all 17 members of the ACIP has triggered a decline in shares of pharmaceutical companies like Novavax (NVAX), Pfizer (PFE), and Merck (MRK) in after-hours trading. Kennedy’s overhaul, aimed at restoring public trust in vaccine science, raises concerns…

Mark J. Bachleda, PharmD, MBA appointed as independent member of the Board of DirectorsDavid Shook, MD appointed as Chief Medical Officer, Mark Meltz, JD as Gen

You can be subject to CSRD compliance, even if your headquarters is in New York, Houston or Silicon Valley.

HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (CLDX) today announced that Denice M. Torres has been elected to the company's Boa

Market Analysis by covering: Exxon Mobil Corp, Home Depot Inc, Johnson & Johnson, Crude Oil WTI Futures. Read 's Market Analysis on Investing.com

Addex Therapeutics (ADXN) has revealed promising findings regarding the anti-tussive effectiveness of its innovative gamma-aminobutyric acid sub-type B receptor

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

AnaptysBio (ANAB) recently conducted a webcast to share encouraging findings from its Phase 2b trial of rosnilimab in treating rheumatoid arthritis. The company

Kenvue carries fewer risks and its products are iconic and essential brands; it offers steady dividends, and long-term growth. Read why KVUE is suitable for dividend investors.

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

Key Highlights: Kenvue (KVUE) shares fell 6% after CEO's comments on seasonal product sales. Analysts' average one-year price target for Kenvue stands at

Outset Medical (OM) appoints Renee Gaeta as the new CFO, succeeding Nabeel Ahmed. The company reaffirms its 2025 financial guidance with projected reven